Logo

Some Drugs and Herbal Products

Small book cover: Some Drugs and Herbal Products

Some Drugs and Herbal Products

Publisher: International Agency for Research on Cancer
Number of pages: 438

Description:
This volume of the IARC Monographs provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin (widely prescribed for the treatment of chronic heart failure), pioglitazone (used for the treatment of type 2 diabetes mellitus), and hydrochlorothiazide (used to treat hypertension).

Home page url

Download or read it online for free here:
Download link
(8.7MB, PDF)

Similar books

Book cover: Gastric Carcinoma: New Insights into Current ManagementGastric Carcinoma: New Insights into Current Management
by - InTech
Gastric cancer is the second most common cause of cancer-related death in the world. The book makes an insight into the assessment of premalignant lesions, management of early gastric cancer, risk and protective factors in gastric carcinogenesis.
(3403 views)
Book cover: Breast CancerBreast Cancer
- American Cancer Society
Breast cancer is a malignant tumor that starts from cells of the breast. A malignant tumor is a group of cancer cells that may grow into surrounding tissues or spread to distant areas of the body. This document refers only to breast cancer in women.
(9443 views)
Book cover: Hepatocellular CarcinomaHepatocellular Carcinoma
by - InTech
Many components of current novel therapeutic modalities for HCC are discussed in the current version of the book within the framework of a multidisciplinary approach with special emphasis on emerging treatment approaches and research strategies.
(3464 views)
Book cover: Ovarian Cancer: The Recognition and Initial ManagementOvarian Cancer: The Recognition and Initial Management
- National Collaborating Centre for Cancer
These clinical guidelines review a number of clinical questions that involve the detection, diagnosis and initial management of ovarian cancer and which focus on areas of uncertainty or where there is a wide variation in clinical practice.
(4727 views)